Mutant Diaminopimelate Dehydrogenase for D-Amino Acid Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing D-amino acids are limited by low yields, multiple steps, and the availability of specific enzymes, making it difficult to efficiently synthesize these important pharmaceutical intermediates.
Innovation Solution
Development of novel mutant diaminopimelate dehydrogenase enzymes that catalyze the reductive amination of 2-ketoacids to produce D-amino acids, allowing for a single-step process with high yields and enantiomeric purity using a nicotinamide cofactor and ammonia.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional resolution methods (diastereomeric crystallization, enzymatic resolution, SMB chiral chromatography) are used to produce D-amino acids, then enantiomeric purity can be achieved, but the maximum theoretical yield is limited to 50%
Solution Approach 1:
Instead of using traditional resolution methods that separate racemic mixtures (maximum 50% yield), the invention uses an engineered dehydrogenase enzyme that directly synthesizes only the desired D-enantiomer from 2-ketoacids, inverting the approach from separation to selective synthesis. This achieves both high enantiomeric purity and theoretical maximum yield.
Solution Approach 2:
The invention modifies the enzyme's catalytic parameters through protein engineering (changing amino acid residues in the active site) to enable stereoselective production of D-amino acids. This parameter change in enzyme specificity allows 100% theoretical yield while maintaining 100% enantiomeric excess.
2Manufacturing precision
If multiple production steps are used to achieve high yield and purity, then product quality improves, but process complexity and time increase
Solution Approach 1:
The invention combines synthesis and purification into a single enzymatic reaction step. The engineered dehydrogenase enzyme produces D-amino acids with 100% enantiomeric excess directly in the reaction mixture, eliminating the need for separate resolution or purification steps. This merging achieves both high purity and simplified process.
Solution Approach 2:
The enzyme is pre-engineered with specific amino acid modifications in the active site that ensure stereoselective catalysis from the outset. This preliminary design of enzyme specificity prevents formation of unwanted enantiomers, eliminating the need for subsequent separation steps and reducing overall process complexity.
3Manufacturing precision
If specific enzymes are used for producing D-amino acids, then enantiomeric excess can be achieved, but enzyme availability and substrate scope are limited
Solution Approach 1:
The engineered dehydrogenase enzyme exhibits broad substrate scope, accepting various 2-ketoacids (aromatic, aliphatic, heterocyclic) while maintaining high stereoselectivity for D-enantiomer production. This universal enzyme can produce multiple different D-amino acids from different substrates, combining high enantiomeric excess with versatility.
Solution Approach 2:
Specific amino acid residues in the enzyme's active site are modified to create a binding environment that accommodates diverse 2-ketoacid substrates while maintaining stereoselective catalysis. These localized modifications in the active site confer both high enantiomeric excess and broad substrate scope.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves 100% theoretical yield and 100% enantiomeric excess of D-amino acids with reduced by-products, overcoming the limitations of existing methods by simplifying the synthesis process and increasing product yield.
Implementation Method 1
novel mutant diaminopimelate dehydrogenase enzymes that catalyze the reductive amination of 2-ketoacids to produce D-amino acids
Implementation Method 2
catalyze the reductive amination of 2-ketoacids to produce D-amino acids
Data Source
AI summary
Polypeptides capable of catalyzing the reductive amination of a 2-ketoacid to its corresponding D-amino acid are provided. The polypeptides can be prepared by mutagenesis of, e.g., a diaminopimelate dehydrogenase. Also provided is a method of making a D-amino acid using a catalytically active polypeptide, wherein a 2-ketoacid is allowed to contact the polypeptide in the presence of a nicotinamide cofactor and ammonia or an ammonia source.